Thursday, August 23, 2012
Publication and contact
VEGF-containing, self-assembling peptide nanofiber scaffolds for
self-assembling peptide nanofiber scaffolds could help promote tissue repair
following myocardial infarction (MI). In rat and porcine models of MI,
intramyocardial injection of the VEGF-containing nanofiber scaffold increased
cardiac function, angiogenesis and arteriogenesis compared with injection of
scaffold or VEGF alone. In the rat model, intramyocardial injection of the
VEGF-containing nanofiber scaffold decreased systemic adverse effects
compared with injection of VEGF itself. Next steps include studies to
evaluate the scaffold's long-term effects and determine its therapeutic
window in the post-MI setting.
Published online Aug. 23, 2012
Patent application filed;
available for licensing
Lin, Y.-D. et al. Sci.
published online Aug. 8,
Contact: Patrick C.H. Hsieh,
National Cheng Kung
University Hospital, Tainan, Taiwan
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]